Secondaries announced 7.20.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Intec Pharma, Ltd. Symbol: NTEC Price: Last trade $8.36 Description: Their ordinary shares currently trade on the Tel Aviv Stock Exchange,[…]